Clinical Trials Browser

Neoplasms × poly ICLC × 90 days × Clear all

NCT06614140 2026-04-22

Personalized Neoantigen Cancer Vaccine for Patients With Solid Tumors

Phase 1/2 Completed

Neoplasms